Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL)

NCT05976997 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Newly Diagnosed Peripheral T-cell Lymphoma

Interventions

DRUG: Duvelisib, Chidamide

Sponsor

Liling Zhang

Collaborators

[object Object]